ClearFlow raised $7.2 million in a new round of equity financing, according to an SEC filing posted this week.
Money in the offering came from five anonymous investors, with the first sale recorded on February 15.
The Anaheim, Calif.-based company is looking for an additional $3 million before closing the offering, according to an SEC filing, which would bring the total possible in the round up to approximately $10.2 million.
Last June, ClearFlow said it won FDA 510(k) clearance for its FlowGlide active clearance technology system designed to prevent or reduce clot occlusions during chest drains.